J Vedrenne

Circulating macrophage colony stimulating factor as a marker of tumour progression.

L Deneux, Véronique Mosseri, J Vedrenne et al. · PubMed · 2002 · 85 citations

Medicine, Immunology, Oncology +15

Chemothermotherapy in the management of retinoblastoma1 1None of the authors have any financial interests in the drugs or devices described in this article.

Livia Lumbroso-Le Rouïc, François Doz, M. Urbieta et al. · Ophthalmology · 2002 · 80 citations

Medicine, Oncology, Pharmacotherapy +6

Functional results after treatment of retinoblastoma

Laurence Desjardins, M Charif Chefchaouni, Christine Lévy et al. · Journal of American Association for Pediatric Ophthalmology and Strabismus · 2002 · 48 citations

Medicine, Oncology, Ophthalmology +6

Homozygous Variant of Antithrombin III : AT III Fontainebleau

Catherine Boyer, M. Wolf, J Vedrenne et al. · Thrombosis and Haemostasis · 1986 · 45 citations

Medicine, Biochemistry, Hematology +13

A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain

F. Boureau, François Saudubray, Christine d’Arnoux et al. · Journal of Pain and Symptom Management · 1992 · 21 citations

Nursing, Pharmaceutics, Pharmacology +17